Allogene Therapeutics (NasdaqGS:ALLO) Q3 2026 Earnings call November 05, 2026 05:00 PM ET Speaker0Please be advised that today's conference is being recorded. I would now like to turn the call over to Christine Cassiano, Chief Corporate Affairs and Brand Strategy Officer. Ms. Cassiano, please go ahead.Speaker1Thank you, operator, and welcome everyone to Allogene's conference call. After the market closed, Allogene issued a press release that provided a business update and financial results for the third qua ...